Neudle.com: dystonia parkinsonism

Differential
(Click to cross reference)

aciduria

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome-related complex

adolescent medicine

advances in neurology

adverse drug reaction

agitation

akathisia

akinesia of eyelid function

alcohol

algorithm

alien hand syndrome

alternating hemiplegia

alternating hemiplegia of childhood

anti basal ganglia antibodies

anti IgLON5

anticholinergic drugs

aphasia

aphasia, progressive, primary

aphonia

applause sign

apraxia

apraxia of eye movements

apraxia of eyelid opening

apraxia, constructional

attention deficit disorder with hyperactivity

atypical

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autonomic dysfunction

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

bent spine syndrome

beta adrenergic blocker

calcification, intracranial

calcium antagonist

calcium antagonist, side effects of

calculations

camptocormia

carbamazepine

carbon monoxide poisoning

CAT scan

CAT scan, abnormal

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, isodense lesion with acute hemorrhage

CAT scan, muscle

catecholamine

central hypoventilation

central nervous system, infection of

cerebral cortical atrophy

cerebral ischemia

cerebral palsy

cerebral vasculature, calcification

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular accident, complications with

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

comprehension, impaired

compression fracture

conjugate gaze, forced

consanguinity

contractures, joint

convergence, impaired

conversion reaction

copper metabolism, abnormal

cortical-basal ganglionic degeneration

creatine phosphokinase(CPK)elevated

crying, pathologic

cultured skin fibroblasts

cyanide poison

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

dementia

depression

developmental milestones, loss of

developmental retardation

dexterity, impaired

diagnostic criteria

differential diagnosis

diplopia

disability, neurological

diurnal variation

dopa responsive dystonia

drug induced neurologic disorders

drug withdrawal

dysarthria

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, causes of

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, axial

dystonia, cervical

dystonia, children

dystonia, classification

dystonia, delayed onset

dystonia, drug induced

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, psychogenic

dystonia, treatment of

dystonic reaction, acute

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, viral

encephalopathy

encephalopathy, progressive

enzyme, defect

epidemiology of neurology

equinovarus

exercise

exercise-induced neurologic dysfunction

extrapyramidal

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial appearance, abnormal

facial expression abnormality

Fahr disease

falling

familial

fine motor function, impaired

flunarizine

fluoxetine

foot deformity

frontal behavioral spatial syndrome

frontal lobe, atrophy

gait disorder

gait, apraxic

galactorrhea

gamma amino butyric acid

gangliosidosis GM1

gaze palsy

gaze palsy, supranuclear

genetic diagnosis, prenatal

genetic neurologic disorders

genetic testing

gests antagoniste

Gilles de la Tourette syndrome

glabellar sign

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

grasp reflex

grimacing

Hallervorden Spatz disease

Hallervorden Spatz disease, late onset

hallucination, visual

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatic failure

hepatolenticular degeneration(Wilson's disease)

hepatosplenomegaly

heralding manifestation

HLA

hoarseness

homovanillic acid

human immunodeficiency virus type 1

iatrogenic neurologic disorders

inborn errors of metabolism

inclusion bodies, intranuclear

intellectual deterioration

intracerebral hemorrhage

iron, brain

Jakob-Creutzfeldt disease

jaw jerk, abnormal

Kayser-Fleischer ring

kyphosis

language disorder in adults

laughing, pathologic

L-dopa

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

Lewy body disease, diffuse

lipid storage disorder of CNS

manganese intoxication

masked facies

medical-legal aspects of neurology

memory, defect of recent

memory, impairment of

meningitis

meningitis, carcinomatous

mental status, abnormal

metabolic disorder, primary

mitochondrial disease

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

movement disorder, treatment of

MRI

MRI pattern

MRI, abnormal

MRI, CAT scan compared to

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, mouse ears

MRI, negative

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple sclerosis

multiple system atrophy

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurochemistry

neurodegeneration with brain iron accumulation

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurologic disease, tempo

neurologic signs

neurologic symptoms

neuronal intranuclear inclusion disease

next-generation sequencing

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

norepinephrine

nystagmus

nystagmus, monocular

obsessive-compulsive disorder

ocular motility, disorders of

ocular myopathy

ocular myopathy, differential diagnosis

oculogyric crisis

old age, neurology of

opened mouth

ophthalmoplegia

optic atrophy

optokinetic nystagmus, abnormal

paraplegia, in flexion

parasomnia

paraspinal muscle

paraspinal muscle weakness

Parkinson disease

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, juvenile

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, on-off phenomena in

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, psychogenic

Parkinson disease, rapid onset

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

paroxysmal nonkinesigenic dyskinesia

pathologic reflex

patient information and support

penguin silhouette sign

penicillamine

personality change

phenothiazine

phenothiazine, dyskinesia associated with

phenylketonuria

Pick's disease

pigmentary retinopathy

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

POLG1 gene

polycythemia, secondary

pons, lesion of

postural abnormality

precipitating factors

primary familial brain calcification

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

propranolol

pseudobulbar palsy

pseudohypoparathyroidism

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

putamen, lesion of, bilateral

quadriplegia

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

reading problem, causes of

recurrent

Red flags

reflex sympathetic dystrophy

release phenomena

renal failure

repetition, impaired

respirations in CNS disease

restless leg syndrome

reversible neurologic disorder

saccadic eye movements, abnormal

salivation, excessive

scoliosis

seizure

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory loss

sensory loss, cortical

sensory tricks

sequencing difficulty

short stature

sinemet

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

slit lamp examination

somnolence

spastic dysphonia

speech disorder

speech disorder, childhood

stimulation, deep brain

stimulation, thalamic

stooped posture

striatal encephalitis

striopallidodentate calcifications, familial idiopathic

subarachnoid hemorrhage

substantia nigra

suck reflex

swallow evaluation

symmetric brain lesions

tardive dyskinesia

tardive dyskinesia, treatment of

thalamus, lesion of-bilateral

torticollis, post traumatic

toxoplasmosis, CNS

trauma

treatment failure

treatment of neurologic disorder

tremor, post traumatic

tyrosine hydroxylase deficiency

visuospatial disturbance

vocal cord paralysis

walking

walking frame

walking, difficulty with

weakness, progressive

X-linked dystonia-parkinsonism syndrome

Showing articles 300 to 350 of 1682 << Previous Next >>

MRI in Methylmalonic Acidemia
Neurol 74:e14, Bindu, P.S.,et al, 2010

Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Arch Neurol 67:58-63, Rabinak,C. &Nirenberg,M., 2010

Practice Parameter: Treatment of Nonmotor Symptoms of Parkinson Disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 74:924-931, Zesiewicz,T.A.,et al, 2010

(-Synuclein Accumulation in Skin Nerve Fibers Revealed by Skin Biopsy in Pure Autonomic Failure
Neurol 74:608-610,536, Shishido,T.,et al, 2010

Pallidal Versus Subthalamic Deep-Brain Stimulation for Parkinsons Disease
NEJM 362:2077-2091, Pollett,K.A., et al, 2010

Huntingtons Disease
BMJ 341:34-40, Novak,M.J. &Tabrizi,S.J., 2010

Effects of a Central Cholinesterase Inhibitor on Reducing Falls in Parkinson Disease
Neurol 75:1263-1269, Chung,K.A.,et al, 2010

A Meta-Regression of the Long-Term Effects of Deep Brain Stimulation on Balance and Gait in PD
Neurol 75:1292-1299, St. George,R.J.,et al, 2010

What Predicts Mortality in Parkinson Disease? A Prospective Population-Based Long-Term Study
Neurol 75:1270-1276, Forsaa,E.B.,et al, 2010

Traumatic Brain Injury - Football, Warfare, and Long-Term Effects
NEJM 363:1293-1296, DeKosky,S.T.,et al, 2010

Road Safety in Drivers With Parkinson Disease
Neurol 73:2112-2119, Uc,E.,et al, 2009

N-Methyl-D-Aspartate Receptor Antibodies in Pediatric Dyskinetic Encephalitis Lethargica
Ann Neurol 66:704-709, Dale,R.,et al, 2009

Imaging-Pathologic Correlation in Corticobasal Degeneration
AJNR 30:1884-1892, Tokumaru,A.,et al, 2009

The Expanding Phenotype of GLUT1-Deficiency Syndrome
Brain & Dev 31:545-552, Brockmann,K., 2009

Othello Syndrome in Parkinson Disease Patients Without Dementia
The Neurologist 15:34-36, Cannas,A.,et al, 2009

Overweight After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease: Long Term Follow-Up
JNNP 80:484-488, Bannier,S.,et al, 2009

High Doses of Deferiprone May Be Associated with Cerebellar Syndrome
BMJ 338:653, Beau-Salinas,F.,et al, 2009

High-Resolution Diffusion Tensor Imaging in the Substantia Nigra of De Novo Parkinson Disease
Neurol 72:1378-1384,1374, Vaillancourt,D.E.,et al, 2009

Deep Brain Stimulation for Primary Generalized Dystonia: Long-Term Outcomes
Arch Neurol 66:465-470, Isaias,I.U.,et al, 2009

Diffusion Abnormalities in the Primary Sensorimotor Pathways in Writers Cramp
Arch Neurol 66:502-508, Delmaire,C.,et al, 2009

Long-Term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Arch Neurol 66:563-570, Parkinson Sutdy Group CALM Cohort Investigators, 2009

Parkinsonism in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Neurol 73:401-403, Tisch,S. &Brew,B., 2009

Long-Term Effects of Pallidal Deep Brain Stimulation in Tradive Dystonia
Neurol 73:53-58, Gruber,D.,et al, 2009

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Clinical Spectrum of Ataxia-Telangiectasia in Adulthood
Neurol 73:430-437, Verhagen,M.M.M.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Family History of Melanoma and Parkinson Disease Risk
Neurol 73:1286-1291, Gao,X.,et al, 2009

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinsons Disease
NEJM 361:1268-1278, 1304, Olanow,C.,et al, 2009

A Multidisciplinary Study of Patients with Early-Onset PD with and Without Parkin Mutations
Neurol 72:110-116,106, Lohmann,E.,et al, 2009

Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients with Advanced Parkinson Disease: A Randomized Controlled Trial
JAMA 301:63-73,104, Weaver,F.M.,et al, 2009

Aicardi-Gouti�res Syndrome
Br Med Bull 89:183-201, Orcesi, S.,et al, 2009

Bilateral Basal Ganglia Lesions in Patients with End-Stage Diabetic Nephropathy
Nephrology 13:68-72, Li, J.,et al, 2008

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Admission International Normalized Ratio and Acute Infarct Volume in Ischemic Stroke
Ann Neurol 64:499-506, Ay,H.,et al, 2008

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008

Levodopa for the Treatment of Parkinsons Disease
NEJM 359:2468-2476, LeWitt,P.A., 2008

Tau Forms in CSF as a Reliable Biomarker for Progressive Supranuclear Palsy
Neurol 71:1796-1803, Borroni,B.,et al, 2008

Rhinorrhea and Olfaction in Parkinson Disease
Neurol 70:487-489, Friedman, J.H.,et al, 2008

Fragile X-Associated Tremor/Ataxia Syndrome: An Aging Face of the Fragile X Gene
Arch Neurol 65:19-25, Amiri,K.,et al, 2008

Increased Risk of Parkinsonism in Women Who Underwent Oophorectomy Before Menopause
Neurol 70:200-209, Rocca,W.A.,et al, 2008

Functional Imaging of the Cerebral Olfactory System in Patients with Parkinsons Disease
JNNP 79:19-24, Westermann,B.,et al, 2008

a-Synuclein Gene Duplication Is Present in Sporadic Parkinson Disease
Neurol 70:43-49,7, Ahn,T.-B.,et al, 2008

A 23-Year-Old Man With Seizures and Visual Deficit
Neurol 70:73-78, Boustany,R.-M.,et al, 2008

Statin Use and the Risk of Parkinson Disease
Neurol 70:1418-1422, Wahner,A.D.,et al, 2008

Use of Antihypertensives and the Risk of Parkinson Disease
Neurol 70:1438-1444, Becker,C.,et al, 2008

Functional Imaging in Parkinson Disease
Neurol 70:1478-1488, Nandhagopal,R.,et al, 2008

Dementia and Survival in Parkinson Disease: A 12-Year Population Study
Neurol 70:1017-1022, Buter,T.C.,et al, 2008

Second Consensus Statement on the Diagnosis of Multiple System Atrophy
Neurol 71:670-676, Gilman,S.,et al., 2008

Attempted and Completed Suicides After Subthalamic Nucleus Stimulation for Parkinsons Disease
JNNP 79:952-954, Soulas,T.,et al., 2008

Update on Blepharospasm: Report from the BEBRF International Workshop
Neurol 71:1275-1282, Hallett,M.,et al, 2008

Showing articles 300 to 350 of 1682 << Previous Next >>